Deepak Fertilisers & Petrochemicals Corp Ltd Q3 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 4 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹20.1K Cr
Crop nutrition business growth driven by specialty fertilizers like Croptek and Smartek, with volumes rising significantly (e.g., Croptek sales volume increasing from 37,000 to 60,000 metric tons). The company expects sustainable EBITDA margins at the consolidated level, supported by ongoing operational efficiencies and premiumization in product mix (Page 16-17).
From Deepak Fertilisers & Petrochemicals Corp Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹1,449
Market Cap
₹20.1K Cr
P/E Ratio
20.4
How does Deepak Fertilisers & Petrochemicals Corp Ltd rank in Chemicals & Petrochemicals?
Compare Deepak Fertilisers & Petrochemicals Corp Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Deepak Fertilisers & Petrochemicals Corp Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.8K Cr, net profit ₹141 Cr.
Full financials →📊 Revenue & Sales Performance
- →Crop nutrition business growth driven by specialty fertilizers like Croptek and Smartek, with volumes rising significantly (e.g., Croptek sales volume increasing from 37,000 to 60,000 metric tons).
- →Capacity expansions underway in Dahej and Gopalpur facilities to meet high demand and sustain supply constraints, expected to go live in H2 of next year.
- →Specialty segment share expected to increase across industrial chemicals and mining chemicals, supporting margin expansion.
- →TAN and WNA volumes expected to grow with peak production in Q4 aligned with mining and infrastructure sector demand.
- →Anticipated stable or gradually improving margins, with pricing pressures offset by volume growth and operational efficiencies.
- →IPA sales growth to continue, especially in pharmaceutical and specialty segments like electronic-grade IPA.
- →Sustainable EBIT margin in crop nutrition expected to improve from current single-digit levels due to premiumization and specialty focus.
📈 Profitability & Margins
- →The company expects sustainable EBITDA margins at the consolidated level, supported by ongoing operational efficiencies and premiumization in product mix (Page 16-17).
- →Crop nutrition business is targeting margin expansion by moving from commodity to specialty products, with continuous quarter-on-quarter growth in margins (Page 17).
- →Capacity expansions in technical ammonium nitrate (Gopalpur) and nitric acid (Dahej) plants are expected to be commissioned in H2 FY '26, supporting volume growth and revenue increase (Page 6, 12, 16).
- →Peak net debt expected around INR 5,500 crores in H2 FY '26, seen as a temporary phase with subsequent cash generation to reduce debt levels (Page 11).
- →Asset turnover post-capex expected at 0.7-0.8, with a rapid ramp-up due to familiarity with capacity and products (Page 16).
- →Long-term strategic shift toward specialty chemicals and fertilizers aimed at driving sustained profitability and growth (Page 12).
- →FY '27 guidance is not yet provided but discussions expected once capacity expansions stabilize (Page 16).
🏗️ Capital Expenditure Plans
- →Deepak Fertilisers has two major capacity expansion projects planned: one in Dahej (nitric acid plant) and one in Gopalpur, Odisha (Technical Ammonium Nitrate - TAN plant).
- →These projects are expected to be commissioned in the second half (H2) of FY '26.
- →Total capex for these two plants is around INR 4,500 crores, with INR 1,300 crores spent so far; the balance will be spent between Q4 FY '25 and project completion in FY '26.
- →For 9 months FY '25, total capex was approximately INR 700-800 crores.
- →The new capex will support higher capacity and faster ramp-up since similar plants already run in Taloja.
- →The company is also exploring debottlenecking opportunities at existing facilities such as Taloja and other businesses like NPK and ANP to improve capacity utilization.
- →Strategic focus includes moving from commodity to specialty products, supported by R&D and possible future investments in specialty sectors like high-purity chemicals and pharmaceutical-grade IPA.
💰 Fundraising & Capital Structure
- →Current net debt stands around INR 3,250 crores.
- →With ongoing capacity expansions, peak net debt is expected around INR 5,500 crores in H2 FY '26.
- →The increase in debt is seen as temporary; operational cash flows are expected to reduce debt levels post ramp-up.
- →No specific mention of new equity fundraising in the transcript.
- →The company is focused on capacity expansions funded primarily through debt.
- →No definitive timeline or plans shared regarding additional fundraising via debt or equity beyond current expansions.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Deepak Fertilisers & Petrochemicals Corp Ltd Q3 FY25 results?
Crop nutrition business growth driven by specialty fertilizers like Croptek and Smartek, with volumes rising significantly (e.g., Croptek sales volume increasing from 37,000 to 60,000 metric tons). The company expects sustainable EBITDA margins at the consolidated level, supported by ongoing operational efficiencies and premiumization in product mix (Page 16-17).
What is Deepak Fertilisers & Petrochemicals Corp Ltd share price analysis?
Deepak Fertilisers & Petrochemicals Corp Ltd currently shows a neutral. The stock trades at a P/E of 20.4 with a market cap of ₹20,127 Cr. Investors should review the full earnings analysis for detailed insights.
Is Deepak Fertilisers & Petrochemicals Corp Ltd planning capital expenditure?
Deepak Fertilisers has two major capacity expansion projects planned: one in Dahej (nitric acid plant) and one in Gopalpur, Odisha (Technical Ammonium Nitrate - TAN plant).
Keep Deepak Fertilisers & Petrochemicals Corp Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.